The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
about
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityEmerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingTemporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brainThe mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaDiscordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor functionTargeting glutamate synapses in schizophreniaComparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primatesGlycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.Deletion of forebrain glycine transporter 1 enhances conditioned freezing to a reliable, but not an ambiguous, cue for threat in a conditioned freezing paradigm.Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophreniaNMDA Receptor Activity in Neuropsychiatric Disorders.Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?Potential role of amino acids in pathogenesis of schizophrenia.The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
P2860
Q24631419-8CF0DA58-EA45-4293-9D5C-4E419A8C9947Q27023967-76110744-5FDC-48DD-B099-A58795331FC5Q28543523-B0CC7B72-956E-41EB-9EE4-D9863239BB23Q30371933-86FD5691-E251-4764-8FAD-FD35CF286C6FQ30386868-708C6BD9-573E-424C-ACB6-B824D26584F3Q30460392-B1B831ED-1F15-42CC-873C-AF5069C8BDD8Q34169978-E01EFD15-0792-4B45-B11C-B720F9099684Q34357077-80CFAADD-79F5-4772-88BD-E7A6AC7050D9Q34381226-D3AC2F45-BEF2-4C76-BCB3-C11AC0E5D27CQ35619874-5C82AF13-1032-42D7-A815-87C4FAA806EEQ37438631-3F09AA12-FED9-40B9-8D70-0C252E034F41Q38114881-13C9043A-1EB3-4304-AB38-1FA7807FA20FQ38172958-D26B57EB-AE81-416A-B0F4-949C1DF23F07Q41706313-C7343782-07E0-4C8C-8E5A-F2B2605DE59BQ44153709-143575F8-33C8-44A0-BC6B-0C2DFB94F301
P2860
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@ast
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@en
type
label
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@ast
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@en
prefLabel
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@ast
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@en
P2093
P2860
P356
P1476
The glycine transporter-1 inhi ...... in normal and transgenic mice.
@en
P2093
Denis Boulay
Olivier Bergis
Patrick Avenet
P2860
P2888
P304
P356
10.1038/NPP.2009.144
P407
P50
P577
2010-01-01T00:00:00Z
P5875
P6179
1045216521